TRIAP1
Gene Information
- Official Symbol: TRIAP1
- Official Name: TP53 regulated inhibitor of apoptosis 1
- Aliases and Previous Symbols: N/A
- Entrez ID: 51499
- UniProt: O43715
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Involved in the modulation of the mitochondrial apoptotic pathway by ensuring the accumulation of cardiolipin (CL) in mitochondrial membranes. In vitro, the TRIAP1:PRELID1 complex mediates the transfer of phosphatidic acid (PA) between liposomes and probably functions as a PA transporter across the mitochondrion intermembrane space to provide PA for CL synthesis in the inner membrane (PubMed:23931759). Likewise, the TRIAP1:PRELID3A complex mediates the transfer of phosphatidic acid (PA) between liposomes (in vitro) and probably functions as a PA transporter across the mitochondrion intermembrane space (in vivo) (PubMed:26071602). Mediates cell survival by inhibiting activation of caspase-9 which prevents induction of apoptosis (PubMed:15735003). {ECO:0000269|PubMed:15735003, ECO:0000269|PubMed:23931759}.
Pfam Domains GO Terms
Pfam Domains
| UPF0203 |
GO Terms
| phosphatidic acid transfer activity |
| positive regulation of phospholipid transport |
| regulation of phospholipid transport |
| negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| negative regulation of release of cytochrome c from mitochondria |
| negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| negative regulation of signal transduction by p53 class mediator |
| regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| regulation of release of cytochrome c from mitochondria |
| positive regulation of anion transport |
| regulation of membrane lipid distribution |
| negative regulation of mitochondrion organization |
| DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
| signal transduction involved in mitotic cell cycle checkpoint |
| signal transduction involved in mitotic G1 DNA damage checkpoint |
| signal transduction involved in mitotic DNA damage checkpoint |
| intracellular signal transduction involved in G1 DNA damage checkpoint |
| signal transduction involved in mitotic DNA integrity checkpoint |
| positive regulation of lipid transport |
| mitotic G1 DNA damage checkpoint |
| mitotic G1/S transition checkpoint |
| G1 DNA damage checkpoint |
| p53 binding |
| signal transduction involved in DNA integrity checkpoint |
| signal transduction involved in DNA damage checkpoint |
| signal transduction involved in cell cycle checkpoint |
| mitochondrial intermembrane space |
| DNA damage response, signal transduction by p53 class mediator |
| positive regulation of cell cycle arrest |
| negative regulation of response to DNA damage stimulus |
| positive regulation of lipid localization |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| cellular response to UV |
| negative regulation of cysteine-type endopeptidase activity |
| phospholipid transport |
| mitotic DNA damage checkpoint |
| negative regulation of intrinsic apoptotic signaling pathway |
| regulation of anion transport |
| negative regulation of G1/S transition of mitotic cell cycle |
| mitotic DNA integrity checkpoint |
| signal transduction in response to DNA damage |
| negative regulation of cell cycle G1/S phase transition |
| regulation of cell cycle arrest |
| regulation of lipid transport |
| cellular response to light stimulus |
| signal transduction by p53 class mediator |
| organophosphate ester transport |
| DNA damage checkpoint |
| regulation of lipid localization |
| response to UV |
| DNA integrity checkpoint |
| regulation of G1/S transition of mitotic cell cycle |
| mitotic cell cycle checkpoint |
| regulation of intrinsic apoptotic signaling pathway |
| regulation of cell cycle G1/S phase transition |
| cellular response to radiation |
| regulation of mitochondrion organization |
| regulation of signal transduction by p53 class mediator |
| cell cycle checkpoint |
| negative regulation of mitotic cell cycle phase transition |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of response to DNA damage stimulus |
| negative regulation of apoptotic signaling pathway |
| negative regulation of cell cycle phase transition |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of endopeptidase activity |
| negative regulation of peptidase activity |
| positive regulation of ion transport |
| positive regulation of cell cycle process |
| lipid transport |
| response to light stimulus |
| negative regulation of mitotic cell cycle |
| cellular response to environmental stimulus |
| cellular response to abiotic stimulus |
| lipid localization |
| negative regulation of cell cycle process |
| negative regulation of proteolysis |
| negative regulation of organelle organization |
| positive regulation of cell cycle |
| regulation of apoptotic signaling pathway |
| regulation of mitotic cell cycle phase transition |
| regulation of endopeptidase activity |
| response to radiation |
| regulation of peptidase activity |
| regulation of cell cycle phase transition |
| negative regulation of hydrolase activity |
| organic anion transport |
| negative regulation of intracellular signal transduction |
| negative regulation of cell cycle |
| anion transport |
| protein-containing complex |
| mitotic cell cycle process |
| regulation of mitotic cell cycle |
| mitotic cell cycle |
| perinuclear region of cytoplasm |
| regulation of ion transport |
| negative regulation of cellular component organization |
| regulation of proteolysis |
| regulation of cellular response to stress |
| regulation of cell cycle process |
| cellular response to DNA damage stimulus |
| negative regulation of catalytic activity |
| membrane organization |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| apoptotic process |
| positive regulation of transport |
| negative regulation of cell death |
| cell cycle process |
| negative regulation of cellular protein metabolic process |
| programmed cell death |
| cell death |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| response to abiotic stimulus |
| regulation of cell cycle |
| positive regulation of transcription by RNA polymerase II |
| mitochondrion |
| negative regulation of signal transduction |
| regulation of hydrolase activity |
| regulation of organelle organization |
| cell cycle |
| negative regulation of cell communication |
| negative regulation of signaling |
| ion transport |
| regulation of response to stress |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of RNA metabolic process |
| regulation of intracellular signal transduction |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PMM2 | 0.754 |
| CRLS1 | 0.717 |
| THG1L | 0.715 |
| DPAGT1 | 0.7 |
| ROMO1 | 0.7 |
| SLC25A26 | 0.698 |
| ALG1 | 0.693 |
| UAP1 | 0.681 |
| TAZ | 0.676 |
| RPE | 0.673 |
| TAMM41 | 0.661 |
| GMPPB | 0.651 |
| GFPT1 | 0.648 |
| HCCS | 0.646 |
| DOHH | 0.642 |
| SRP14 | 0.634 |
| RPTOR | 0.63 |
| ATXN10 | 0.628 |
| RTCB | 0.626 |
| HSPD1 | 0.62 |
| VEZT | 0.615 |
| RNMT | 0.607 |
| TIMM13 | 0.599 |
| TRNT1 | 0.597 |
| SUPV3L1 | 0.597 |
| CASP9 | 0.596 |
| PAM16 | 0.591 |
| ALG5 | 0.59 |
| ALG13 | 0.59 |
| DHPS | 0.587 |
| NAE1 | 0.586 |
| OPA1 | 0.585 |
| ATP5B | 0.584 |
| ATP5O | 0.582 |
| PELO | 0.582 |
| ADSL | 0.581 |
| CYCS | 0.581 |
| DNLZ | 0.581 |
| PPA2 | 0.578 |
| PLAA | 0.577 |
| AASDHPPT | 0.576 |
| UTP23 | 0.573 |
| APAF1 | 0.572 |
| UHRF1 | 0.565 |
| ATP5J | 0.565 |
| RPIA | 0.564 |
| CHCHD4 | 0.564 |
| ENY2 | 0.564 |
| ALG6 | 0.56 |
| AARS | 0.559 |
| MRPS34 | 0.556 |
| EXOC4 | 0.555 |
| CBFB | 0.555 |
| ATP5A1 | 0.555 |
| BAP1 | 0.553 |
| MRPS14 | 0.552 |
| TRMT10A | 0.545 |
| TMEM41B | 0.542 |
| MEAF6 | 0.541 |
| DAP3 | 0.54 |
| HARS | 0.54 |
| GTF3C6 | 0.54 |
| PPCS | 0.538 |
| MRPS16 | 0.538 |
| ATP5H | 0.537 |
| BAK1 | 0.535 |
| UBE2G2 | 0.535 |
| WDR24 | 0.535 |
| TRMT5 | 0.534 |
| HSD17B10 | 0.534 |
| LSM10 | 0.533 |
| ALG14 | 0.532 |
| CSNK2B | 0.532 |
| COX16 | 0.532 |
| ATIC | 0.532 |
| MED16 | 0.532 |
| DAD1 | 0.531 |
| KDSR | 0.529 |
| ZRSR2 | 0.527 |
| PDSS1 | 0.527 |
| GTF3C2 | 0.526 |
| YARS2 | 0.525 |
| CEP57 | 0.524 |
| MRPL21 | 0.523 |
| SEC61G | 0.523 |
| DHRSX | 0.523 |
| GTF3C3 | 0.521 |
| SEC62 | 0.52 |
| BCS1L | 0.52 |
| PGM3 | 0.52 |
| MRPS11 | 0.519 |
| ENO1 | 0.518 |
| KIAA0391 | 0.518 |
| ATP5D | 0.515 |
| RPP21 | 0.515 |
| TBCA | 0.514 |
| MTOR | 0.514 |
| ALG2 | 0.514 |
| TEN1 | 0.514 |
| ORAOV1 | 0.513 |
| DOLK | 0.513 |
| FH | 0.513 |
| PPP2R3C | 0.513 |
| DPF2 | 0.511 |
| TXNL4B | 0.509 |
| TSEN54 | 0.508 |
| UBA3 | 0.508 |
| ELAC2 | 0.508 |
| MRPS18A | 0.507 |
| MRPS6 | 0.503 |
| SSB | 0.503 |
| MFN1 | 0.502 |
| MRPL23 | 0.501 |
| TUFM | 0.5 |
| SDHA | 0.499 |
| CCT7 | 0.498 |
| GTF3C4 | 0.498 |
| THOC6 | 0.498 |
| HAUS8 | 0.497 |
| VDAC2 | 0.497 |
| UQCRC2 | 0.497 |
| NSD1 | 0.497 |
| PGGT1B | 0.497 |
| DDX55 | 0.497 |
| TTI2 | 0.496 |
| TOMM22 | 0.494 |
| DARS2 | 0.493 |
| MRPL15 | 0.493 |
| ATP5F1 | 0.493 |
| EIF3F | 0.491 |
| DDX20 | 0.491 |
| UBE2M | 0.489 |
| PGS1 | 0.488 |
| SRD5A3 | 0.488 |
| GFER | 0.487 |
| SERF2 | 0.486 |
| YARS | 0.486 |
| RPUSD4 | 0.485 |
| TXNRD1 | 0.485 |
| MRPS2 | 0.485 |
| RPN1 | 0.483 |
| SARS2 | 0.481 |
| UBE2K | 0.481 |
| TMEM242 | 0.48 |
| GEMIN8 | 0.48 |
| TKT | 0.479 |
| ATP2A2 | 0.479 |
| GFM1 | 0.478 |
| TPRKB | 0.478 |
| PPP5C | 0.477 |
| TRMT61A | 0.477 |
| RAD1 | 0.477 |
| NUPL2 | 0.476 |
| FNTA | 0.475 |
| MRPL47 | 0.475 |
| RNASEH1 | 0.475 |
| FAF2 | 0.474 |
| OIP5 | 0.474 |
| MRPL20 | 0.474 |
| RFT1 | 0.474 |
| SCO2 | 0.473 |
| GEMIN7 | 0.473 |
| BRWD1 | 0.473 |
| GEMIN5 | 0.472 |
| VRK1 | 0.472 |
| NSMCE1 | 0.471 |
| MRPS33 | 0.471 |
| PARL | 0.47 |
| WDR59 | 0.47 |
| POLR3H | 0.47 |
| PIK3R4 | 0.47 |
| COQ3 | 0.467 |
| EIF4E | 0.467 |
| EXOC3 | 0.467 |
| TELO2 | 0.466 |
| DDOST | 0.466 |
| GNB1L | 0.466 |
| CCDC101 | 0.466 |
| UBQLN1 | 0.466 |
| GEMIN6 | 0.465 |
| SLC35B1 | 0.465 |
| MRP63 | 0.465 |
| VMP1 | 0.464 |
| C17orf89 | 0.464 |
| ATP5L | 0.464 |
| MBTPS2 | 0.464 |
| TTC4 | 0.464 |
| RBFA | 0.462 |
| HARS2 | 0.462 |
| TGS1 | 0.462 |
| CBX3 | 0.461 |
| MED23 | 0.461 |
| MRPS9 | 0.46 |
| ATP5C1 | 0.458 |
| DR1 | 0.457 |
| MRPS5 | 0.457 |
| MARCH5 | 0.457 |
| VARS2 | 0.456 |
| COQ5 | 0.456 |
| PHB | 0.455 |
| FASTKD5 | 0.455 |
| CTDNEP1 | 0.455 |
| TIMM23B | 0.454 |
| MRPS26 | 0.454 |
| RBMX2 | 0.454 |
| LSM11 | 0.454 |
| C11orf57 | 0.453 |
| UQCRQ | 0.452 |
| RABGGTB | 0.451 |
| PNPT1 | 0.451 |
| TBCB | 0.451 |
| KCTD5 | 0.45 |
| LAMTOR5 | 0.45 |
| TIMM22 | 0.449 |
| SLC25A19 | 0.449 |
| GTF2A2 | 0.449 |
| TARS2 | 0.448 |
| SELRC1 | 0.447 |
| UXT | 0.447 |
| MRPL53 | 0.447 |
| TIMM8B | 0.447 |
| GATC | 0.446 |
| ATP5I | 0.446 |
| NARS | 0.446 |
| GFM2 | 0.445 |
| NUP50 | 0.444 |
| EPRS | 0.443 |
| TOMM40 | 0.443 |
| OTUD5 | 0.443 |
| LONP1 | 0.443 |
| WBSCR16 | 0.443 |
| PARS2 | 0.442 |
| COX7B | 0.441 |
| TTI1 | 0.44 |
| MIS18A | 0.439 |
| C12orf65 | 0.439 |
| MED4 | 0.439 |
| EARS2 | 0.438 |
| LAMTOR4 | 0.438 |
| METAP2 | 0.438 |
| TOP3A | 0.437 |
| MRPL27 | 0.436 |
| PISD | 0.436 |
| STT3A | 0.434 |
| TBP | 0.434 |
| ELF2 | 0.432 |
| COX17 | 0.432 |
| MAPK14 | 0.432 |
| RARS2 | 0.431 |
| WDR1 | 0.431 |
| GABPA | 0.431 |
| ZFP91 | 0.431 |
| SEC16A | 0.431 |
| GTF3A | 0.43 |
| MRPS21 | 0.43 |
| C10orf2 | 0.429 |
| PPP4C | 0.429 |
| TMED10 | 0.428 |
| NBN | 0.428 |
| DIABLO | 0.426 |
| SEC63 | 0.426 |
| DHX30 | 0.425 |
| UBE2J1 | 0.425 |
| TSEN34 | 0.425 |
| MLLT1 | 0.424 |
| HIST1H4I | 0.424 |
| NXT1 | 0.424 |
| DUSP12 | 0.422 |
| SRP68 | 0.421 |
| DDX1 | 0.421 |
| EEF1E1 | 0.42 |
| MRPL36 | 0.419 |
| ASXL2 | 0.419 |
| CARS | 0.418 |
| TPK1 | 0.417 |
| ELP3 | 0.417 |
| SRP72 | 0.416 |
| URM1 | 0.416 |
| TRIM28 | 0.416 |
| FBXO11 | 0.415 |
| MARS | 0.415 |
| ALG8 | 0.415 |
| TEFM | 0.415 |
| IRF2BP2 | 0.414 |
| WDR92 | 0.414 |
| BTF3 | 0.413 |
| MRPS23 | 0.412 |
| DNAJC3 | 0.412 |
| RFK | 0.411 |
| GTPBP10 | 0.41 |
| CHORDC1 | 0.409 |
| UQCR10 | 0.408 |
| UBA5 | 0.407 |
| NDUFAF4 | 0.407 |
| PDAP1 | 0.406 |
| TPI1 | 0.406 |
| NDUFB5 | 0.406 |
| CTC1 | 0.406 |
| ELP2 | 0.405 |
| SPCS2 | 0.404 |
| OSGEP | 0.404 |
| TAF1A | 0.404 |
| TMEM126B | 0.403 |
| PYROXD1 | 0.403 |
| CDIPT | 0.403 |
| SLMO2 | 0.403 |
| DHX29 | 0.402 |
| MRPL34 | 0.402 |
| ZFX | 0.401 |
| GLMN | 0.401 |
| POLR3B | 0.401 |
| PDPK1 | 0.401 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 700/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 1/1 |
| bile duct | 26/28 |
| blood | 27/28 |
| bone | 25/26 |
| breast | 29/33 |
| central nervous system | 55/56 |
| cervix | 4/4 |
| colorectal | 17/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 15/16 |
| kidney | 20/21 |
| liver | 19/20 |
| lung | 74/75 |
| lymphocyte | 16/16 |
| ovary | 25/26 |
| pancreas | 24/24 |
| peripheral nervous system | 12/16 |
| plasma cell | 14/15 |
| prostate | 1/1 |
| skin | 22/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 22/22 |
| urinary tract | 28/29 |
| uterus | 3/5 |
Essentiality in NALM6
- Essentiality Rank: 1713
- Expression level (log2 read counts): 5.18
Expression Distribution
TRIAP1 Expression in NALM6 Cells: 5.18